News
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the most profitable biotech stocks to invest in now. TD Cowen analyst Tyler Van ...
Genmab A/S (NASDAQ:GMAB) is one of the most profitable biotech stocks to invest in now. In a report released on July 14, ...
Insider Monkey on MSN28m
TD Cowen Sees Upside for Thermo Fisher (TMO) With Modest Q2 GrowthThermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best low volatility stocks to buy according to analysts. On July 16, ...
Bio-Techne Corporation (NASDAQ:TECH) is one of the most profitable biotech stocks to invest in now. On July 9, TD Cowen ...
TD Cowen has raised its price target for Strategy’s stock from $590 to $680 per share, citing the company’s deepening role as ...
United Therapeutics Corporation (NASDAQ:UTHR) is one of the Best Extremely Profitable Stocks to Buy Right Now. On July 15, ...
CSX experienced a tough second quarter and first half of 2025, compared to the prior-year’s periods, but saw some sequential ...
Klaviyo, Inc. (NYSE:KVYO) is one of the Most Promising New Technology Stocks According to Wall Street Analysts. On June 23, ...
In a report released today, William Katz from TD Cowen reiterated a Buy rating on Invesco, with a price target of $29.00. The company’s shares opened today at $21.55. Take advantage of TipRanks ...
In addition to TD Cowen, Centene also received a Hold from Robert W. Baird’s Michael Ha in a report issued yesterday. However, on the same day, TR | OpenAI – 4o reiterated a Buy rating on Centene ...
TD Cowen on potential opportunities in Canadian equities. The potential impact of Canadian mortgage resets in 2025. Why demographic uncertainty could be a major challenge for the Canadian economy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results